1. Home
  2. LRMR vs SMID Comparison

LRMR vs SMID Comparison

Compare LRMR & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • SMID
  • Stock Information
  • Founded
  • LRMR N/A
  • SMID 1960
  • Country
  • LRMR United States
  • SMID United States
  • Employees
  • LRMR N/A
  • SMID N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • SMID Building Materials
  • Sector
  • LRMR Health Care
  • SMID Industrials
  • Exchange
  • LRMR Nasdaq
  • SMID Nasdaq
  • Market Cap
  • LRMR 183.8M
  • SMID 167.5M
  • IPO Year
  • LRMR N/A
  • SMID 1995
  • Fundamental
  • Price
  • LRMR $2.18
  • SMID $28.70
  • Analyst Decision
  • LRMR Strong Buy
  • SMID
  • Analyst Count
  • LRMR 8
  • SMID 0
  • Target Price
  • LRMR $19.63
  • SMID N/A
  • AVG Volume (30 Days)
  • LRMR 1.3M
  • SMID 11.4K
  • Earning Date
  • LRMR 04-30-2025
  • SMID 05-27-2025
  • Dividend Yield
  • LRMR N/A
  • SMID N/A
  • EPS Growth
  • LRMR N/A
  • SMID 866.67
  • EPS
  • LRMR N/A
  • SMID 1.45
  • Revenue
  • LRMR N/A
  • SMID $78,508,000.00
  • Revenue This Year
  • LRMR N/A
  • SMID N/A
  • Revenue Next Year
  • LRMR N/A
  • SMID N/A
  • P/E Ratio
  • LRMR N/A
  • SMID $20.79
  • Revenue Growth
  • LRMR N/A
  • SMID 31.77
  • 52 Week Low
  • LRMR $1.61
  • SMID $25.03
  • 52 Week High
  • LRMR $11.20
  • SMID $51.96
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 54.85
  • SMID 45.82
  • Support Level
  • LRMR $1.80
  • SMID $28.89
  • Resistance Level
  • LRMR $2.33
  • SMID $33.82
  • Average True Range (ATR)
  • LRMR 0.18
  • SMID 2.15
  • MACD
  • LRMR 0.04
  • SMID -0.11
  • Stochastic Oscillator
  • LRMR 90.00
  • SMID 24.51

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: